Clinical Trial

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
Trial Details
NCT Number NCT07643233
Lead Sponsor AJU Pharm Co., Ltd.
Conditions Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
Enrollment 36 participants
Start Date 2026-07
Primary Completion 2026-07 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-11